Chun-kit S. Yuen
Hong Kong Science And Technology Park
Hong Kong, China
Hong Kong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Nasal RNA-scaffold-protein vaccine protects mice from human H5N1 clade 2.3.4.4b virus lethal infection and safeguards against vaccine-unmatched viruses.
Journal: EBioMedicine
Published: September 12, 2025
An RNA-Scaffold Protein Subunit Vaccine for Nasal Immunization.
Journal: Vaccines
Published: September 07, 2023
An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection in small animal models.
Journal: Nature communications
Published: May 18, 2023
A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants.
Journal: Emerging microbes & infections
Published: March 11, 2022
Loss of orf3b in the circulating SARS-CoV-2 strains.
Journal: Emerging microbes & infections
Published: November 18, 2020
Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein.
Journal: mBio
Published: October 21, 2020
Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in primary human cell culture and hamsters.
Journal: Research square
Published: October 14, 2020
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2.
Journal: Nature
Published: September 30, 2020
Suppression of SARS-CoV-2 infection in ex-vivo human lung tissues by targeting class III phosphoinositide 3-kinase.
Journal: Journal of medical virology
Published: August 28, 2020
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.
Journal: Emerging microbes & infections
Published: June 13, 2020
SMRT sequencing revealed the diversity and characteristics of defective interfering RNAs in influenza A (H7N9) virus infection.
Journal: Emerging microbes & infections
Published: May 16, 2019
Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: January 28, 2017
Last Updated: 09/26/2026